BioSpace News Archive

Darrin Ball has joined Consigli as a Project Executive. Ball will be responsible for team management and delivery of projects from pre-construction to closeout and assist with business development in the life science & academic markets..

New technology reduces amount of time spent preparing treatment plans in cancer genomic medicine by half in verification trials conducted with the Department of Hematology and Oncology

70.6% of week 16 HiSCR responders maintain response throughout week 40 while 41.8% of non-responders become responders (total HiSCR rate = 56.3% at end of treatment)

The division previously had three clinical divisions and one nonclinical division. Under the restructuring, it will six divisions, three for oncology.

Biotech and pharmaceutical companies from across the globe provide updates on their business and pipelines.

Both Owlstone and Thermo Fisher will work together to integrate Thermo Fisher’s Orbitrap gas chromatography mass spectrometry instrumentation into Owlstone Medical’s Breath Biopsy platform.

Your unique traits are likely a match for many jobs, and a Unique Selling Proposition can help position you with employers as uniquely qualified.

Houston, TX Fannin Innovation Studio announces its receipt of a $2,000,000 Phase II Small Business Innovation Research grant from the National Institute of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development for development of its ChorioAnchor device, in partnership with Texas Children’s Hospital, Baylor College of Medicine, and Texas A&M University

Independent SMO Panthera Biopartners has opened its first clinical trials site in Preston, Lancashire, UK.

Completion of public offering and listing of American Depository Shares (ADSs) on Nasdaq Global Select Market under the symbol “GMAB.” Total gross proceeds from the issuance of new shares amounted to USD 582 million (DKK 3,873 million) with a corresponding increase in share capital of 3,277,500 ordinary shares or 32,775,000 ADSs